Evidence map›Paper›PMID 27811860›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2017

Evaluation of a Web-based decision aid for people considering the APOE genetic test for Alzheimer risk.

Michael Ekstract, Golde I Holtzman, Kye Y Kim, Susan M Willis, Doris T Zallen

Open access · bronzeAbstract readValidation Study
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Editorial: Implications of Emerging Uses of Genetic Testing for Alzheimer's Disease.The journal of prevention of Alzheimer's disease · 2023
    Article
  4. Article
  5. Informed Consent in the Genomics Era.Cold Spring Harbor perspectives in medicine · 2020
    Review
  6. Review
  7. "Well, good luck with that": reactions to learning of increased genetic risk for Alzheimer disease.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michael EkstractBreakneck Turtles Productions, New York, New York, USA.ORCID 0000-0003-0864-3521
Golde I HoltzmanDepartment of Statistics, Virginia Tech, Blacksburg, Virginia, USA.
Kye Y KimCarilion Clinic-Center for Healthy Aging and Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA.ORCID 0000-0003-2543-5230
Susan M WillisVirginia Tech Center for Survey Research, Blacksburg, Virginia, USA.
Doris T ZallenDepartment of Science and Technology in Society, Virginia Tech, Blacksburg, Virginia, USA.ORCID 0000-0002-5688-5640
Carilion Clinic · USVirginia Tech · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWith the increasing interest in apolipoprotein E (APOE) genetic testing to estimate the risk of developing late-onset Alzheimer disease, new educational tools are needed to help people make the best decision for themselves about whether to undergo this test. This study evaluated an online tool to assist in this decision process.

methodsA prototype decision aid was studied in a two-part survey that collected data from participants before and after they examined the decision aid. Both surveys had multiple-choice options and opportunities for open-ended responses, yielding quantitative and qualitative information. The responses before and after use of the aid were compared for each participant.

resultsA total of 1,262 individuals completed both surveys. The overall effectiveness of the decision aid was shown by three measures: 94% found the decision aid very helpful or somewhat helpful; general knowledge was increased; and some people changed their minds about APOE genetic testing, with 35% shifting to a higher likelihood of undergoing the test and 20% to a lower likelihood. Suggestions for improvements were noted and incorporated into the online tool.

conclusionThis decision aid can provide useful educational assistance to many individuals as they consider APOE genetic testing as well as facilitate further discussions with their health-care providers.Genet Med advance online publication 03 November 2016.

Indexed as

Decision Support TechniquesGenetic TestingInternetAdultAgedAged, 80 and overAlzheimer DiseaseApolipoproteins EFemaleHealth Status IndicatorsHumansMaleMiddle AgedYoung AdultApolipoproteins E

Identifiers

PMID27811860
OpenAlexW2547842485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.